Propel Bio Management »

Syndax Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 83k 23.80

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (HIGH)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Fulcrum Therapeutics Comm (FULC)
Avidity Biosciences Comm (RNA)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Kura Oncology Comm (KURA)
Telesat Corp Comm (TSAT)
Kymera Therapeutics Comm (KYMR)

View all positions for Propel Bio Management

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
BlackRock
Kynam Capital Management
Vanguard Group
venBio Select Advisor
T. Rowe Price Investment Management
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
Morgan Stanley
Geode Capital Management
OrbiMed Advisors
Bank of America Corporation
Sofinnova Ventures

View all funds holding Syndax Pharmaceuticals